1. The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis

   • Thomas S. Griffith
   • Troy J. Kemp

   Original Article 14 June 2003 Pages: 175 - 184

   

2. Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents

   • Patrizia Vernole
   • Rita Pepponi
   • Stefania D'Atri

   Original Article 19 June 2003 Pages: 185 - 192

   

3. Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer

   • Bruno Reigner
   • Toru Watanabe
   • Susan Grange

   Original Article 29 May 2003 Pages: 193 - 201

   

4. Peptides designed from molecular modeling studies of the ras-p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on normal pancreatic acinar cell growth

   • Mecheal Kanovsky
   • Josef Michl
   • Matthew R. Pincus

   Original Article 29 May 2003 Pages: 202 - 208

   

5. Population pharmacokinetics of oral busulfan in children

   • Brunhild Schiltmeyer
   • Thomas Klingebiel
   • Georg Hempel

   Original Article 17 June 2003 Pages: 209 - 216

   

6. Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy

   • Keith T. Flaherty
   • James P. Stevenson
   • Peter J. O'Dwyer

   Original Article 17 June 2003 Pages: 217 - 222

7. Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia

   • Francis J. Giles
   • Gary Guangping Shi
   • Susan M. O'Brien

   Original Article 03 June 2003 Pages: 223 - 228

   

8. Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders

   • Apostolia M. Tsimberidou
   • Dawn E. Colburn
   • Francis J. Giles

   Original Article 29 May 2003 Pages: 229 - 234

   

9. Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1

   • Shadan Ali
   • Olivia Aranha
   • Philip Agop Philip

   Original Article 14 June 2003 Pages: 235 - 246

   

10. Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer

    • J. Feliu
    • G. Martín
    • M. González-Barón

    Original Article 29 May 2003 Pages: 247 - 252

11. The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by modulation of extracellular pH

    • James L. Flowers
    • Robert M. Hoffman
    • David J. Adams

    Original Article 03 June 2003 Pages: 253 - 261